<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Before and/or after chemotherapy was administered to patients with Burkitt's <z:hpo ids='HP_0002665'>lymphoma</z:hpo> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">BL</z:e>) or <z:e sem="disease" ids="C0079748" disease_type="Neoplastic Process" abbrv="">lymphoblastic lymphosarcoma</z:e> (LLS), their sera and those of matched controls were tested for antibodies to Epstein-Barr virus (EBV) capsid antigen (VCA) and early antigen by the indirect immunofluorescence method </plain></SENT>
<SENT sid="1" pm="."><plain>Ten of the 16 BL patients were Arab children and 8 of the 11 LLS patients were Jews of Asian-African origin </plain></SENT>
<SENT sid="2" pm="."><plain>Although half the <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">BL</z:e> patients did not have elevated antibody titers when their disease was diagnosed, significantly higher ones were detected in the <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">BL</z:e> group as compared with the LLS patients and their matched controls; Arab patients had the highest titers </plain></SENT>
<SENT sid="3" pm="."><plain>IgM antibodies specific for VCA were found in 2 patients concurrently with elevated titers </plain></SENT>
<SENT sid="4" pm="."><plain>We found no correlation between the clinical course of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">BL</z:e> and the patients' antibody titers to EBV </plain></SENT>
</text></document>